Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Report Code: HLC156B

Publish Date: Mar 2024

Publisher: BCC Publishing

Category: Health Maintenance

Download Report Overview

Single User License: $4650

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Report Includes

  • 57 data tables and 83 additional tables
  • An overview and industry analysis of the global markets for emerging insulin drug and delivery technologies, with an emphasis on plastic insulin syringes and vials
  • Analyses of the global market trends, with historical market revenue data (sales figures) for 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimate of the actual market size and revenue growth forecast, and a corresponding market share analysis by product type, application and region
  • A look at the emerging technologies that have potential in the diabetes market, with improved glucose control, along with improved delivery methods
  • Examination of the current state of the insulin drug and delivery industry structure, focusing on technological updates and issues surrounding insulin pens and insulin syringes, ongoing research activities, and regulatory and pricing scenarios
  • Discussion of market dynamics, clinical trial applications, regulations, and penetration of technologies in the pharmaceutical and biotechnology markets
  • Discussion of the ESG developments and how they impact corporate performance, ratings and matrices and consumer attitude, as well as the ESG practices of leading pharma and biotech companies
  • Review of the key patent grants/publications for insulin as a drug, along with its delivery methods
  • Analysis of the competitive landscape based on recent developments and segmental revenues of leading companies
  • Profiles of the leading market players

Report Scope

This report discusses the implications of the growing diabetes epidemic on the global and regional markets for emerging insulin drug and delivery technologies. It discusses companies in the relevant pharmaceutical and medical industries and provides profiles of the leading players as well as an update on M&A activity. The report’s patent analysis focuses on developments in Japan, Europe and the U.S. Five-year global sales forecasts are provided for the major categories of insulin drug and delivery technologies and devices categories.

This report segments the global market into four regions:

  • North America.
  • Europe.
  • Asia-Pacific.
  • Rest of the World (RoW).

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $51.6 billion
Market size forecast $88.9 billion
Growth rate CAGR of 9.8% from 2023 to 2028
Units considered $ Millions
Segments covered By Product Type, Application, and Geographic Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market Drivers
  • Rising Prevalence of Diabetes
  • Next Generation of Type 2 Diabetes Treatments
  • Growing Awareness of Diabetes as a Global Epidemic
  • Technological Advances
  • Market Acceptance of Oral Anti-Diabetes Drug Treatments
Companies studied
JOHNSON & JOHNSON SERVICES INC.INSULET CORP.
ASTRAZENECAB. BRAUN SE
BDCARDINAL HEALTH
DEBIOTECH SADIABELOOP SA
EMPERRA GMBH E-HEALTH TECHNOLOGIESEMBECTA CORP.
F. HOFFMANN-LA ROCHE LTD.LIFESCAN IP HOLDINGS LLC.
LILLYMEDTRONIC
NOVO NORDISK A/SNUGEN MEDICAL DEVICES
OWEN MUMFORD LTD.SANOFI
SOOIL DEVELOPMENTS CO. LTD.TANDEM DIABETES CARE INC.
TERUMO CORP.YPSOMED
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global market for insulin drug delivery devices was valued at $55.8 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.8% to reach $88.9 billion by 2028.
Key drivers of the insulin drug delivery devices market are increasing incidence & prevalence of diabetes, changing lifestyle habits, growing geriatric population, and increasing prevalence of chronic diseases.
The insulin drug delivery devices market is segmented based on product type, application, and region.
The Insulin syringes and vials segment will dominate the market by the end of 2028.

Analyst Credentials

Bejini Sandeep Kumar– Assistant Manager - Life Sciences Research
Sandeep Kumar has over 11 years of experience in pharmaceutical and medical equipment research and consulting. With expertise lying in business research studies, such as industry analysis, strategic and financial analysis, opportunity assessment and competitor intelligence. Sandeep has extensive experience in market research and analysis, specializing in healthcare, medical devices, biotechnology, healthcare IT, pharmaceuticals, and others. He holds a bachelor’s degree in Biotechnology and a Post Graduate degree in Business Management from Liverpool John Moores University (LJMU).

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials160Free
Chapter- 1: Introduction4Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market Overview14Free
Chapter- 4: Global Market for Emerging Insulin Drug and Delivery Technologies, by Type20Free
Chapter- 5: Global Market for Emerging Insulin Drug Delivery Devices, by Application3Free
Chapter- 6: Global Market for for Insulin Drug Delivery Devices, by Region11Free
Chapter- 7: Regulatory Landscape7Free
Chapter- 8: Sustainability in the Insulin Drug and Delivery Market: An ESG Perspective5Free
Chapter- 9: Emerging Technologies4Free
Chapter- 10: Patent Analysis4Free
Chapter- 11: M&A and Venture Funding Outlook6Free
Chapter- 12: Competitive Landscape4Free
Chapter- 13: Company Profiles71Free
Chapter- 14: Appendix3Free
Published - Aug-2013| Analyst - Shalini Shahani Dewan| Code - HLC156A

Report Highlights

Report Includes

  • An overview of global insulin drugs and delivery in pharmaceutical and biotechnology markets with classification and usage in diabetes types, with a focus on insulin syringes and vials.
  • Analyses of global market trends, with data from 2011 and 2012, estimates for 2013 and 2018 and projections of compound annual growth rates (CAGRs) through 2018.
  • Evaluation of emerging technologies in the insulin drug and delivery field that have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods.
  • Patent identifications for insulin as a drug, along with its delivery methods.

Related Reports

Prefilled Syringes: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC223B

The global market for prefilled syringes is expected to grow from $14.5 billion in 2024 and is projected to reach $22.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2024 to 2029.

Type 2 Diabetes Treatment: Global Market Outlook

Published - Jan 2023 | Publisher - BCC Publishing | Code - HLC287A

The goal is to provide an up-to-date analysis of the global type 2 diabetes treatment market and future opportunities in the market. It presents a thorough and up-to-date global assessment of the market and business of the type 2 diabetes treatment. This will help industry participants, suppliers, government bodies, associations, and customers make the informed decisions needed to compete and succeed in the marketplace. The scope of the study includes the various types of medicines involved in type 2 diabetes treatment and management. Blood glucose monitoring, diagnostic systems and devices, and insulin-delivery devices used in the treatment of type 2 diabetes, however, have been excluded from this study.

Global Diabetic Care Devices Market

Published - Oct 2020 | Publisher - BCC Publishing | Code - MDS019A

The global market for diabetes monitoring devices should grow from $19.7 billion in 2020 to $27.0 billion by 2025 with a compound annual growth rate (CAGR) of 6.5% for the period of 2020-2025.

Latest Development, Product Innovations and Treatments for Diabetes

Published - Mar 2020 | Publisher - Paul Taylor | Code - HLC249A

The global diabetes treatment market should grow from $80.9 billion in 2019 to $103.2 billion by 2024 at a compound annual growth rate (CAGR) of 5.0% for the period of 2019-2024.

Recent Reports

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials
Sample Report